Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Last Hour:
Last 24 Hours:

Global Cancer Vaccines Market 2016 Share, Trend, Segmentation and Forecast to 2022

Friday, October 7, 2016 4:11
% of readers think this story is Fact. Add your two cents.

(Before It's News)


According to researchers, the Global Cancer Vaccines market is accounted for $2.25 billion in 2015 and is expected to reach $10.00 billion by 2022 growing at a CAGR of 23.7%. Factors such as rising number of cancer patients, increasing ageing population and awareness of vaccines are fueling the market. However, less availability of vaccines and advanced treatments in underdeveloped regions may limit the market growth.

Request a sample report @

North America accounted for the largest share in the market followed by Asia Pacific. The favourable growth is attributed to supportive government and other organisations such as World health organisation and GAVI initiatives.

Some of the key players in Global Cancer Vaccines market include Oxford BioMedica, Vaccinogen Inc., GlaxoSmithKline, Sanofi India Limited-P.P. Enterprises, Juvaris Biotherapeutics, Merk&co, Prima BioMed Ltd, Cytos Biotechnology AG, Ubivac, duro BioTech, AstraZeneca plc., and MedImmune, LLC. 

Disease Indication Covered: 
• Cervical cancer 
• Esophageal cancer 
• Liver cancer 
• Prostate cancer 
• Lung cancer 
• Breast cancer 
• Stomach cancer

Technologies Covered: 
• Inactivated Vaccines 
• Peptide/protein vaccines 
• Synthetic Vaccines 
• Toxoid Vaccines 
• Live Attenuated Vaccines 
• Recombinant Vector Vaccines 
• Antigen vaccines 
• Dendritic Cell Vaccines 
• Subunit Vaccines 
• Heat shock protein vaccines 
• DNA- and vector-based vaccines 
• Conjugate Vaccines 
• Anti-idiotype vaccines 
• Cancer stem cell vaccines

End Users Covered: 
• Adults 
• Paediatrics 

Vaccine Types Covered: 
• Therapeutic Vaccines 
• Preventive Vaccines

What our report offers: 
- Market share assessments for the regional and country level segments 
- Market share analysis of the top industry players 
- Strategic recommendations for the new entrants 
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets 
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) 
- Strategic recommendations in key business segments based on the market estimations 
- Competitive landscaping mapping the key common trends 
- Company profiling with detailed strategies, financials, and recent developments 
- Supply chain trends mapping the latest technological advancements

Buy this report @

Table of Contents

1 Executive Summary 

2 Preface 
2.1 Abstract 
2.2 Stake Holders 
2.3 Research Scope 
2.4 Research Methodology 
2.4.1 Data Mining 
2.4.2 Data Analysis 
2.4.3 Data Validation 
2.4.4 Research Approach 
2.5 Research Sources 
2.5.1 Primary Research Sources 
2.5.2 Secondary Research Sources 
2.5.3 Assumptions 

3 Market Trend Analysis 
3.1 Introduction 
3.2 Drivers 
3.3 Restraints 
3.4 Opportunities 
3.5 Threats 
3.6 Technology Analysis 
3.7 End User Analysis 
3.8 Emerging Markets 

4 Porters Five Force Analysis 
4.1 Bargaining power of suppliers 
4.2 Bargaining power of buyers 
4.3 Threat of substitutes 
4.4 Threat of new entrants 
4.5 Competitive rivalry 

5 Global Cancer Vaccines Market, By Disease Indication 
5.1 Introduction 
5.2 Cervical cancer 
5.3 Esophageal cancer 
5.4 Liver cancer 
5.5 Prostate cancer 
5.6 Lung cancer 
5.7 Breast cancer 
5.8 Stomach cancer 

6 Global Cancer Vaccines Market, By Technology 
6.1 Introduction 
6.2 Inactivated Vaccines 
6.3 Peptide/protein vaccines 
6.4 Synthetic Vaccines 
6.5 Toxoid Vaccines 
6.6 Live Attenuated Vaccines 
6.7 Recombinant Vector Vaccines 
6.8 Antigen vaccines 
6.9 Dendritic Cell Vaccines 
6.10 Subunit Vaccines 
6.11 Heat shock protein vaccines 
6.12 DNA- and vector-based vaccines 
6.13 Conjugate Vaccines 
6.14 Anti-idiotype vaccines 
6.15 Cancer stem cell vaccines 

7 Global Cancer Vaccines Market, By End User 
7.1 Introduction 
7.2 Adults 
7.3 Pediatrics 

8 Global Cancer Vaccines Market, By Vaccine Type 
8.1 Therapeutic Vaccines 
8.2 Preventive Vaccines 

9 Global Cancer Vaccines Market, By Geography 
9.1 North America 
9.1.1 US 
9.1.2 Canada 
9.1.3 Mexico 
9.2 Europe 
9.2.1 Germany 
9.2.2 France 
9.2.3 Italy 
9.2.4 UK 
9.2.5 Spain 
9.2.6 Rest of Europe 
9.3 Asia Pacific 
9.3.1 Japan 
9.3.2 China 
9.3.3 India 
9.3.4 Australia 
9.3.5 New Zealand 
9.3.6 Rest of Asia Pacific 
9.4 Rest of the World 
9.4.1 Middle East 
9.4.2 Brazil 
9.4.3 Argentina 
9.4.4 South Africa 
9.4.5 Egypt 

10 Key Developments 
10.1 Agreements, Partnerships, Collaborations and Joint Ventures 
10.2 Acquisitions & Mergers 
10.3 New Product Launch 
10.4 Expansions 
10.5 Other Key Strategies 

11 Company Profiling 
11.1 Oxford BioMedica 
11.2 Vaccinogen Inc. 
11.3 GlaxoSmithKline 
11.4 Sanofi India Limited-P.P. Enterprises 
11.5 Juvaris Biotherapeutics 
11.6 Merk&co 
11.7 Prima BioMed Ltd 
11.8 Cytos Biotechnology AG 
11.9 Ubivac 
11.10 duro BioTech 
11.11 AstraZeneca plc 
11.12 MedImmune, LLC 
11.13 Nova Rx Corporation 
11.14 Argos Therapeutics 
11.15 Prima BioMed Ltd 

Complete report details @


Contact US:


Partner Relations & Marketing Manager

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.